Using Benlysta to battle lupus? You could soon be taking it at home instead of at the infusion center.
New research and technology are making it easier than ever to take medications that cannot be delivered in pill form. GSK recently announced that the FDA has approved a self-injectable, subcutaneous formulation of belimumab (Benlysta) for the treatment of autoantibody-positive systemic lupus erythematosus (SLE).
While Benlysta has been available since 2011, it needed to be administered by infusion in a hospital or clinic setting. Patients will now be able to dose themselves at home (after receiving training from their healthcare provider) because of this new approval.